Pharmaceuticals stocks in India
Every listed pharmaceuticals company on NSE and BSE in our database, largest first, with its valuation, profitability, latest quarterly growth, one-year return and next results date.
There are 224 listed companies in the Pharmaceuticals industry on NSE and BSE in our database, 128 of them with full financials.
The largest by market capitalisation are Sun Pharmaceutical Industries Limited (₹432,120 Cr), Divi's Laboratories Limited (₹245,532 Cr), Torrent Pharmaceuticals Limited (₹181,333 Cr).
Among the 99 companies worth more than ₹500 Cr, the median P/E of the profitable ones is 39.4 and the median return on equity is 12.3%.
Fastest sales growth in the latest quarter (year on year, above ₹500 Cr): Marksans Pharma +163%, Neuland Laboratories +136%, Zota Health +122%.
Next to report results: Dr. Reddy's on 23 Oct.
Pharmaceuticals companies by market cap
| # | Company | Market cap | P/E | ROE | Qtr sales YoY | Qtr profit YoY | Return 1Y | Next results |
|---|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA | ₹432,120 Cr | 35.70 | 14.5% | +10.5% | +27.0% | +10.7% | — |
| 2 | Divi's Laboratories LimitedDIVISLAB | ₹245,532 Cr | 83.94 | 17.5% | +27.8% | +65.5% | +56.8% | — |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM | ₹181,333 Cr | 84.11 | 25.7% | +54.8% | +3.3% | +35.0% | — |
| 4 | Zydus Lifesciences LimitedZYDUSLIFE | ₹114,284 Cr | 26.82 | 15.7% | +16.2% | +14.5% | +12.4% | — |
| 5 | Cipla LimitedCIPLA | ₹108,576 Cr | 32.35 | 9.7% | +2.3% | -39.2% | -11.0% | — |
| 6 | Laurus Labs LimitedLAURUSLABS | ₹107,198 Cr | 98.31 | 20.6% | +29.1% | +123.9% | +121.3% | — |
| 7 | Mankind Pharma LimitedMANKIND | ₹104,707 Cr | 50.65 | 12.7% | +12.9% | +29.1% | +0.3% | — |
| 8 | Dr. Reddy's Laboratories LimitedDRREDDY | ₹100,475 Cr | 30.70 | 8.6% | -5.6% | -69.2% | -5.4% | 23 Oct |
| 9 | Aurobindo Pharma LimitedAUROPHARMA | ₹96,479 Cr | 26.00 | 9.8% | +16.3% | +25.2% | +52.8% | — |
| 10 | Lupin LimitedLUPIN | ₹92,880 Cr | 17.34 | 23.9% | +31.9% | +87.8% | +3.5% | — |
| 11 | Glenmark Pharmaceuticals LimitedGLENMARK | ₹65,787 Cr | 36.60 | 17.1% | +23.1% | +927.9% | +14.8% | — |
| 12 | Alkem Laboratories LimitedALKEM | ₹62,413 Cr | 28.54 | 15.8% | +10.9% | -21.6% | -5.2% | — |
| 13 | Biocon LimitedBIOCON | ₹60,361 Cr | 144.82 | 1.2% | +10.0% | +53.4% | +4.1% | — |
| 14 | Abbott IndiaABBOTINDIA | ₹57,033 Cr | 39.46 | 30.3% | — | — | -11.1% | — |
| 15 | IPCA Laboratories LimitedIPCALAB | ₹49,300 Cr | 35.76 | 17.1% | +20.8% | +82.2% | +43.9% | — |
| 16 | Gland Pharma LimitedGLAND | ₹47,418 Cr | 46.14 | 9.9% | +22.3% | +96.7% | +45.7% | — |
| 17 | GlaxoSmithKline Pharmaceuticals LimitedGLAXO | ₹46,944 Cr | 43.96 | 47.1% | +16.6% | +15.7% | +1.2% | — |
| 18 | Ajanta Pharma LimitedAJANTPHARM | ₹44,748 Cr | 39.42 | 25.1% | +24.8% | +30.9% | +43.8% | — |
| 19 | Emcure Pharmaceuticals LimitedEMCURE | ₹36,891 Cr | 36.21 | 20.6% | +22.8% | +36.0% | +46.2% | — |
| 20 | Wockhardt LimitedWOCKPHARMA | ₹33,862 Cr | 95.93 | 7.1% | +25.9% | +199.1% | +41.2% | — |
| 21 | Sai Life Sciences LimitedSAILIFE | ₹32,734 Cr | 95.45 | 13.8% | +6.2% | +15.6% | +74.8% | — |
| 22 | Neuland Laboratories LimitedNEULANDLAB | ₹27,591 Cr | 75.76 | 19.4% | +136.3% | +666.0% | +45.0% | — |
| 23 | Rubicon Research LimitedRUBICON | ₹26,925 Cr | 127.35 | — | — | — | — | — |
| 24 | Piramal Pharma LimitedPPLPHARMA | ₹26,231 Cr | 106.19 | 3.0% | +17.4% | -161.3% | +1.4% | — |
| 25 | Acutaas Chemicals LimitedACUTAAS | ₹26,170 Cr | 137.12 | — | +59.1% | +70.4% | +126.5% | — |
| 26 | Shilpa Medicare LimitedSHILPAMED | ₹20,812 Cr | 69.96 | 11.5% | +44.9% | +115.2% | +168.5% | — |
| 27 | Granules India LimitedGRANULES | ₹20,363 Cr | 32.62 | 12.3% | +82.3% | +159.0% | +55.0% | — |
| 28 | Caplin Point Laboratories LimitedCAPLIPOINT | ₹20,006 Cr | 29.49 | 18.9% | +19.6% | +18.8% | +20.5% | — |
| 29 | Pfizer LimitedPFIZER | ₹17,654 Cr | 24.42 | 17.2% | +6.2% | -39.6% | -22.5% | — |
| 30 | Cohance Lifesciences LimitedCOHANCE | ₹17,267 Cr | 178.71 | — | -23.1% | -197.4% | -49.8% | — |
| 31 | Alivus Life Sciences LimitedALIVUS | ₹16,871 Cr | 27.98 | 18.1% | +6.4% | +31.2% | +45.2% | — |
| 32 | Eris Lifesciences LimitedERIS | ₹16,489 Cr | 24.77 | 17.1% | +13.0% | +14.6% | -26.8% | — |
| 33 | Alembic Pharmaceuticals LimitedAPLLTD | ₹16,025 Cr | 23.77 | 11.9% | +25.7% | +12.7% | -11.6% | — |
| 34 | Jubilant Pharmova LimitedJUBLPHARMA | ₹15,828 Cr | 45.04 | 5.0% | +1385.3% | +3217.6% | -6.7% | — |
| 35 | AstraZeneca Pharma India LimitedASTRAZEN | ₹15,078 Cr | 131.04 | 13.2% | — | — | -33.2% | — |
| 36 | Natco Pharma LimitedNATCOPHARM | ₹14,979 Cr | 13.83 | 11.7% | -44.7% | -55.5% | -2.5% | — |
| 37 | Marksans Pharma LimitedMARKSANS | ₹14,755 Cr | 28.30 | 17.2% | +163.0% | +231.7% | +92.2% | — |
| 38 | Concord Biotech LimitedCONCORDBIO | ₹14,375 Cr | 51.98 | 13.7% | +26.2% | +31.0% | -13.5% | — |
| 39 | Sudeep Pharma LimitedSUDEEPPHRM | ₹13,552 Cr | 155.11 | — | — | — | — | — |
| 40 | Akums Drugs and Pharmaceuticals LimitedAKUMS | ₹12,449 Cr | 42.53 | 8.8% | +13.9% | +56.1% | +74.5% | — |
| 41 | CORONA Remedies LimitedCORONA | ₹12,412 Cr | 117.71 | — | — | — | — | — |
| 42 | Viyash Scientific LimitedVIYASH | ₹10,200 Cr | 84.31 | 4.2% | +2073.4% | +1460.3% | — | — |
| 43 | Strides Pharma Science LimitedSTAR | ₹9,999 Cr | 25.74 | 12.5% | +11.2% | +50.0% | +29.2% | — |
| 44 | Blue Jet Healthcare LimitedBLUEJET | ₹9,398 Cr | 44.84 | 15.4% | -17.4% | -14.2% | -18.5% | — |
| 45 | Procter & Gamble Health LimitedPGHL | ₹8,897 Cr | 24.84 | 68.2% | +7.3% | +45.7% | -15.8% | — |
| 46 | Aarti Pharmalabs LimitedAARTIPHARM | ₹8,782 Cr | 41.22 | 10.0% | +38.7% | +53.8% | +14.9% | — |
| 47 | Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹8,735 Cr | 126.96 | — | — | — | -22.7% | — |
| 48 | Symbiotec Pharmalab LimitedSYMBIOTEC | ₹7,520 Cr | — | — | — | — | — | — |
| 49 | Supriya Lifescience LimitedSUPRIYA | ₹7,493 Cr | 37.81 | 16.5% | +30.8% | -30.9% | +25.6% | — |
| 50 | Morepen Laboratories LimitedMOREPENLAB | ₹7,327 Cr | 51.82 | 11.3% | +34.1% | +394.0% | +166.4% | — |
| 51 | Bliss GVS Pharma LimitedBLISSGVS | ₹7,269 Cr | 51.13 | 11.9% | +37.6% | +15.8% | +363.1% | — |
| 52 | Sanofi India LimitedSANOFI | ₹6,995 Cr | 42.22 | — | — | — | -37.8% | — |
| 53 | Innova Captab LimitedINNOVACAP | ₹6,684 Cr | 13.45 | 45.6% | +33.9% | +42.3% | +39.5% | — |
| 54 | Senores Pharmaceuticals LimitedSENORES | ₹6,215 Cr | 47.39 | 14.0% | +30.6% | +43.8% | +92.7% | — |
| 55 | IOL Chemicals and Pharmaceuticals LimitedIOLCP | ₹6,146 Cr | 36.60 | 9.3% | +37.1% | +89.8% | +89.1% | — |
| 56 | Jeena Sikho Lifecare LimitedJSLL | ₹5,976 Cr | 25.25 | 50.7% | +28.8% | +28.5% | -41.2% | — |
| 57 | FDC LimitedFDC | ₹5,469 Cr | 18.76 | 11.7% | +3.0% | +9.5% | -27.6% | — |
| 58 | Orchid Pharma LimitedORCHPHARMA | ₹5,021 Cr | 225.88 | 1.7% | +0.2% | +25.4% | +34.2% | — |
| 59 | Gujarat Themis Biosyn LimitedGUJTHEM | ₹4,969 Cr | — | — | — | — | -7.3% | — |
| 60 | Novartis IndiaNOVARTIND | ₹4,852 Cr | 52.12 | 11.4% | +8.3% | -13.8% | — | — |
P/E "n/m" means the company made a loss over the last four quarters. Quarterly growth compares the latest quarter with the same quarter a year earlier. "—" means the figure is not available.
More pharmaceuticals companies
Upcoming pharmaceuticals results
Frequently asked questions
Which are the largest pharmaceuticals stocks in India?
By market capitalisation: Sun Pharmaceutical Industries Limited (₹432,120 Cr), Divi's Laboratories Limited (₹245,532 Cr), Torrent Pharmaceuticals Limited (₹181,333 Cr), Zydus Lifesciences Limited (₹114,284 Cr), Cipla Limited (₹108,576 Cr).
How many pharmaceuticals companies are listed in India?
224 companies listed on NSE and BSE are classified in the Pharmaceuticals industry on this page, which merges the exchanges' and data vendors' labels for the same business.
What is the average P/E of pharmaceuticals stocks?
The median P/E of profitable pharmaceuticals companies worth more than ₹500 Cr is 39.4, based on trailing-twelve-month profit and the latest close.
When do pharmaceuticals companies announce their results?
Upcoming board meetings for results: Dr. Reddy's Laboratories Limited on 23 Oct 2026.